News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Martin Steven Robert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Martin Steven Robert (Director) has filed a Form 4 on Ensysce Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.13, valued at
$62.6k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 23,000 options to buy
@ $3.15, valued at
$72.5k
|
|
| 05/24/2019 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.|
Txns:
| Granted 149,362 options to buy
@ $3.15, valued at
$470.5k
|
|
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2016 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on AmpliPhi Biosciences Corp|
Txns:
| Granted 99,919 options to buy
@ $2.85, valued at
$284.8k
|
|
| 02/24/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2014 |
4
| Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 75,000 options to buy
@ $2.36, valued at
$177k
|
|
| 05/24/2013 |
4
| Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Bought 20,000 shares
@ $2.85, valued at
$57k
Bought 20,000 warrants
@ $3.4, valued at
$68k
|
|
| 04/01/2013 |
4
| Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 1,371 options to buy
@ $2.68, valued at
$3.7k
|
|
| 02/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/20/2012 |
4
| Martin Steven Robert (Interim CEO and CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 75,000 options to buy
@ $2.035, valued at
$152.6k
|
|
| 11/30/2012 |
4
| Martin Steven Robert (Interim CEO & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 2,083 options to buy
@ $2.2, valued at
$4.6k
|
|
| 03/07/2012 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 195,000 options to buy
@ $3.23, valued at
$629.9k
|
|
| 06/06/2011 |
4
| Martin Steven Robert (CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 150,000 options
@ $5.02, valued at
$753k
|
|
| 03/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|